Pfizer's quarterly sales miss, shares drop, breakup questions raised
This article was originally published in Scrip
Executive Summary
It wasn’t a pretty first quarter for Pfizer. Sales were more than a half billion dollars short of expectations, operating profit missed a target and the company’s full-year earnings forecast was lowered.